Harrow Health, Inc. (HROW) vs STAAR Surgical Company (STAA)

A side-by-side comparison of Harrow Health, Inc. and STAAR Surgical Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs STAA

growth of $100 · dividends reinvested · last 10y
HROW +821.1% (+24.9%/yr)STAA +144.0% (+9.3%/yr)HROW compounded faster over this window
05001k2kStart $10020182020202220242026$921$244
HROW STAA

HROW vs STAA: by the numbers

  • •HROW is the larger company ($1.13B vs $1.10B market cap).
  • •STAA is profitable (1.13% net margin) while HROW runs a net loss (-13.51%).
  • •HROW grew revenue faster over the past five years (34.52% vs 10.49% CAGR).

Metrics side by side

Valuation

MetricHROWSTAA
P/E ratioN/A276.87
Forward P/EN/A76.31
P/S ratio4.103.25
P/B ratio74.433.02
EV / EBITDAN/A22.47
FCF yield0.47%N/A

Profitability

MetricHROWSTAA
Gross margin73.28%76.23%
Operating margin14.18%-19.19%
Net margin-13.51%1.13%
ROE-244.91%1.05%
ROIC1.81%4.80%

Growth (annualized)

MetricHROWSTAA
Revenue CAGR (5Y)34.52%10.49%
Total return CAGR (5Y)27.66%-28.41%

Frequently asked

Which has grown faster, HROW or STAA?
Over the past five years, HROW grew revenue faster — HROW at a 34.52% CAGR versus STAA at 10.49%.
Is HROW or STAA more profitable?
STAA runs the higher net margin — HROW at -13.51% versus STAA at 1.13%.
How have HROW and STAA total returns compared?
Over the past 10 years, HROW delivered 23.49% and STAA delivered 9.25% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.